Business growth ADC Therapeutics from 4/26/21

News editor
press@blackterminal.com

ADC Therapeutics has received FDA approval for Zynlonta. It is intended to treat patients with relapsed or refractory large cell lymphoma after specific systemic therapy.

ADC Therapeutics

ADCT

$4.54

-1.52%

Review

Source:

ir.adctherapeutics.com

News editor

Write your comment first

News feed

MTS-Bank's profit increased by more than 30% in the first quarter%

5/17/24 MBNK

Bank Saint Petersburg reports for the first quarter of 2024

5/17/24 BSPB

Shareholders of Rosbank approved dividends for 2023

5/17/24 ROSB

Shareholders of Chelyabinsk Press-Forging Plant approved dividends for 2023

5/17/24 CHKZ

HeadHunter can launch its own social network in the summer

5/17/24 HHRU

Shareholders of Perm Energy Supply Company approved dividends for 2023

5/16/24 PMSB

Kamaz develops its own tourist bus

5/16/24 KMAZ

The Board of Directors of Leeuwenhoek recommended paying dividends out of the retained earnings of previous years in the amount of no more than 50 million rubles or ₽0.9445 per ordinary share. The last day of buying securities for receiving dividends is June 27, 2024. The dividend yield may be 1.59%.